The sharp decline in G1 Therapeutics' stock price and the subsequent trading halt are likely to create uncertainty among investors and could lead to increased volatility when trading resumes. The circuit breaker indicates a significant sell-off, which typically has a negative impact on investor sentiment in the short term.